Researchers at the San Francisco VA Medical Center have identified the mechanism by which minocycline, a medication currently being studied for the treatment of neurodegenerative diseases including Parkinson's disease and Huntington's disease, protects brain and nerve cells from damage.
The science and politics of stem cell research were presented last week by Deepak Srivastava and David L. Gollaher as a part of Gladstone's Science for Life lecture series.
David Agard, PhD, UCSF'S first QB3 scientific director and a major force in conceiving and launching the institute, has announced he is stepping down from the position to return full time to his own research.
"I've seen so much here. I'm not sure I'd ever see this much in a lifetime of practice in the US," says Joanne Jorissen of her extraordinary first six months as a volunteer midwife at Bottom Hospital in Lilongwe, Malawi.